Lyfegen

Lyfegen

Private
BaselHealthcare & Life Scienceshttps://lyfegen.com

Last Round

Series A

Dec 11, 2024

Total Funding Raised

$16.64M

Momentum Score

25 /100

Company Overview

Lyfegen is a health tech company providing a software platform for access, pricing, and rebate management for health insurances, governments, and pharmaceutical companies.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Healthcare Analytics, Revenue Cycle, InsurTech, Compliance

Business Model

B2B

Customer Profile

Subscription SaaS, Government Contracts, Services & Consulting, Data as a Service

AI Layer

Application

Keywords

value-based contractingdrug pricing managementrebate managementoutcomes-based contractingmarket access softwareVBApharma pricingP&R softwarerebate analyticshealthcare SaaScontracting simulatorpricing agreement databasegovernment contracting

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lyfegen Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Lyfegen Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Series ADec 11, 2024
Series ASep 20, 2022
SeedSep 1, 2020
SeedApr 17, 2019

Key People

Founding team and executive leadership

Nico Julian Mros

Chief Customer Experience Officer Founder

Founding Team

Girisha Fernando

CEO Founder

Founding Team

Ronen Fischler

Advisory Board Member Interim Chief Revenue Officer

Executive Team

Lyfegen Investors

Notable investors and investment history

InvestorRounds
APEX VenturesSeries A
aMoonSeries A
TX VenturesSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Launched AI Contracting Companion for drug access solutions.

  • Jan 1, 2025

    Collaborating with EVERSANA to revolutionize drug pricing and access.

Lyfegen Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Lyfegen Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Lyfegen's valuation, stock price, and market status.

Firmographic Details

HeadquartersBasel
Employee Range57
Year Founded2018
Last FundingDec 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.